“MyOme Develops Cross-Ancestry Breast Cancer Polygenic Risk Score, Plans Product Launch” — GenomeWeb

“NEW YORK – Personalized genomics company MyOme presented data at the recent American Society of Clinical Oncology conference demonstrating its ability to train and validate a cross-ancestry polygenic risk score (caPRS) for breast cancer.”

Read full article here…

MyOme, Inc. 535 Middlefield Road, Menlo Park, CA 94025 I www.myome.com